Presented by :
B.Sunil Kumar Nayak
 Name : ABC
 Age : 60 years
 Sex : Female
 Dept : General Medicine
 C/o Fever with chills since 10 days
 Dry cough since 10 days
 Breathlessness ( on & off ) since 6 days
 Burning micturation since 5 days
 Medical history : History DM
 Medication history : Metformin+Glimipride
 Social history : Nothing significant
 Family history : Nothing significant
 Allergies : Nil known allergies
S - Subjective Evidence
O - Objective Evidence
A - Assessment
P - Planning
 PROVISIONAL DIAGNOSIS:-
UROSEPSIS UNDER EVALUATION….?
 E.S.R : 60 mm / 1st hr ( 0-20 )
 W.B.C : 18,300 cells / dl ( 4k-11k)
 Hb : 10.8 g/dl ( 13-17 g/dl )
 PR : 82/min ( 72-76 )
FINAL DIAGNOSIS:-
UROSEPSIS
 To maintain the body temperature
 Resuscitate the patient using supportive measures to correct
the hypoxia condition.
 To eradicate the organism from the body.
 To prevent the complications associated with urosepsis.
S.I
NO
DRUGS
(Generic names)
DOSE ROA FRE DA DS
1 Normal saline 2 pint I.V - 1 2
2 Inj.Levofloxacin 500mg I.V B.D 1 2
3 Inj.Pantoprazole 40 mg I.V OD 1 2
4 Inj.Ondansetron 4mg I.V SOS 1 2
5 Tab.Paracetamol 650 mg P.O SOS 1 2
6 Syp.Disodium hydrogen citrate
with water
2 tbsp P.O T.I.D 1 2
DAYS PROGRESS
DAY
-1
O/E Patient is c/c
PR :82/min, B.P :110/70mmhg, R.S :BAE +
Lab data
Blood urea :30 mg/dl, Sr.creatinine :0.8 mg/dl, R.B.S :71 mg/dl
Na+:137 m.mol/L, K+:3.1 m.mol/L, Cl-:101 m.mol/L
C.U.E
Color:Pale yellow, R.B.C:NIL, Proteins :Trace, Pus cells : 2-4cells,
Glucose :Negative, Epithelial cells :6-8cells
Malarial parasite, Dengue, HIV Antibody, HBsAG: Negative
DAY-2 O/E: Pt is c/c, PR:76/min, BP:110/70mmhg, CVS:s1s2+, P/A:soft
LAB DATA
U.S.G Abdomen:No sonographic abnormalities were seen
Chest x Ray: No abnormalities detected
 Body temperature is maintained
 organism was eliminated from the body
 No other complications associated with the disease
were seen
 Closely monitor the vital signs like Heart rate,
Blood pressure, Respiratory rate, Urine output
and vigilance activity.
Drug – Drug interactions :
Levofloxacin < > ondansetron
MOA
 May causes the prolongation of QT interval may result in
ventricular arrhymias including sudden death.
Management
 Monitor the plasma levels of levofloxacin
 Advice the patient about the symptoms of this DI
Discharge medications:
 Tab.ofloxacin
20mg-po-bd * 10 days
 Tab.methylcobalamin
500mcg-po-od * 10 days
 Syp.disodium hydrogen citrate – 2tbsp in a glass of
water –po-tid
 Tab.rantidine
300mg-po-od * 7 days
Follow up advice :
Review after 1 week
1.About Disease
2.About Medication
3.About life style modifications
Case on Urosepsis

Case on Urosepsis

  • 1.
  • 2.
     Name :ABC  Age : 60 years  Sex : Female  Dept : General Medicine
  • 3.
     C/o Feverwith chills since 10 days  Dry cough since 10 days  Breathlessness ( on & off ) since 6 days  Burning micturation since 5 days
  • 4.
     Medical history: History DM  Medication history : Metformin+Glimipride  Social history : Nothing significant  Family history : Nothing significant  Allergies : Nil known allergies
  • 5.
    S - SubjectiveEvidence O - Objective Evidence A - Assessment P - Planning
  • 6.
  • 7.
     E.S.R :60 mm / 1st hr ( 0-20 )  W.B.C : 18,300 cells / dl ( 4k-11k)  Hb : 10.8 g/dl ( 13-17 g/dl )  PR : 82/min ( 72-76 ) FINAL DIAGNOSIS:- UROSEPSIS
  • 8.
     To maintainthe body temperature  Resuscitate the patient using supportive measures to correct the hypoxia condition.  To eradicate the organism from the body.  To prevent the complications associated with urosepsis.
  • 9.
    S.I NO DRUGS (Generic names) DOSE ROAFRE DA DS 1 Normal saline 2 pint I.V - 1 2 2 Inj.Levofloxacin 500mg I.V B.D 1 2 3 Inj.Pantoprazole 40 mg I.V OD 1 2 4 Inj.Ondansetron 4mg I.V SOS 1 2 5 Tab.Paracetamol 650 mg P.O SOS 1 2 6 Syp.Disodium hydrogen citrate with water 2 tbsp P.O T.I.D 1 2
  • 10.
    DAYS PROGRESS DAY -1 O/E Patientis c/c PR :82/min, B.P :110/70mmhg, R.S :BAE + Lab data Blood urea :30 mg/dl, Sr.creatinine :0.8 mg/dl, R.B.S :71 mg/dl Na+:137 m.mol/L, K+:3.1 m.mol/L, Cl-:101 m.mol/L C.U.E Color:Pale yellow, R.B.C:NIL, Proteins :Trace, Pus cells : 2-4cells, Glucose :Negative, Epithelial cells :6-8cells Malarial parasite, Dengue, HIV Antibody, HBsAG: Negative DAY-2 O/E: Pt is c/c, PR:76/min, BP:110/70mmhg, CVS:s1s2+, P/A:soft LAB DATA U.S.G Abdomen:No sonographic abnormalities were seen Chest x Ray: No abnormalities detected
  • 11.
     Body temperatureis maintained  organism was eliminated from the body  No other complications associated with the disease were seen
  • 12.
     Closely monitorthe vital signs like Heart rate, Blood pressure, Respiratory rate, Urine output and vigilance activity.
  • 13.
    Drug – Druginteractions : Levofloxacin < > ondansetron MOA  May causes the prolongation of QT interval may result in ventricular arrhymias including sudden death. Management  Monitor the plasma levels of levofloxacin  Advice the patient about the symptoms of this DI
  • 14.
    Discharge medications:  Tab.ofloxacin 20mg-po-bd* 10 days  Tab.methylcobalamin 500mcg-po-od * 10 days  Syp.disodium hydrogen citrate – 2tbsp in a glass of water –po-tid  Tab.rantidine 300mg-po-od * 7 days Follow up advice : Review after 1 week
  • 15.